Neuro-Oncology Reviews

Volume 27 Number 34
10 December 2025

Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 34, 10 December

Bao Y, Chen Z, Su Y, Guo T, Du H, Jia X.
From neuroinflammation to gliomagenesis: immune drivers of malignant transformation in the CNS.
Front Immunol. 2025 Dec 1;16:1682030. doi: 10.3389/fimmu.2025.1682030. PMID: 41403936. Review. ˍ

Jiang T, Nam DH, Ram Z, Poo WS, Wang J, Boldbaatar D, Mao Y, Ma W, Mao Q, You Y, Jiang C, Yang X, Tergaonkar V, Zhang W, Wang Z, Kang C, Qiu X, Li S, Chen L, Li X, Liu Z, Bai H, Yao Y, Li S, Wu A, Mou Y, Sai K, Li G, Wei X, Liu X, Zhang Z, Dai Y, Lv S, Wang L, Lin Z, Dong J, Xu G, Ma X, Yu R, Kang D, Liu Y, Li G, Zhang S, Qu Y, Wang Y, Zhang C, Chen B, You G, Wang Y, Wang Y, Bao Z, Fan X, Liu X, Zhao Z, Li Y, Wang Z, Li G, Fang S, Liu Y, Shan X, Liu Y, Chai R, Hu H, Chen J, Yan W, Cai J, Wang Y; Chinese Glioma Cooperative Group (CGCG), Society for Neuro-Oncology of China (SNOChina), Chinese Brain Cancer Association (CBCA), Chinese Glioma Genome Atlas (CGGA), Asian Glioma Genome Atlas (AGGA) network.
Updated Clinical practice guidelines for the management of adult diffuse gliomas.
Cancer Lett. 2025 Dec 1:218185. doi: 10.1016/j.canlet.2025.218185. PMID: 41338443. Guidelines˰ ˍ

Tang E, Chen JY.
Shaping the glioblastoma microenvironment to enhance CAR-NK immunotherapy.
Front Immunol. 2025 Dec 1;16:1681966. doi: 10.3389/fimmu.2025.1681966. PMID: 41403931. Review. ˍ

Zheng B, Han Y, Zhang H.
Role of matrix metalloproteinases in the invasion of glioblastoma and drug interventions (Review).
Int J Mol Med. 2025 Dec 1;57(2):33. doi: 10.3892/ijmm.2025.5704. PMID: 41347826. Review. ˍ

Zamani H, Saeb M, Monadi S, Alizade-Harakiyan M, Akhavan A, Khodaei A, Molazadeh M, Farajollahi A.
Comparative effectiveness of advanced radiotherapy techniques for brain cancers: A systematic review with an emphasis on dosimetric variability.
Phys Med. 2025 Dec 3;140:105682. doi: 10.1016/j.ejmp.2025.105682. PMID: 41343911. Review. ˍ

Duran G, Pichardo-Rojas D, Ali AH, Passias P, Downes A, Ray WZ, Zipfel GJ, Shakir HJ, Bauer A, Jea A, Dunn IF, Zuccato JA, Graffeo CS, Janjua MB.
Comparing Isocitrate Dehydrogenase Inhibitors with Procarbazine, Lomustine, and Vincristine Chemotherapy for Oligodendrogliomas.
Cancers (Basel). 2025 Dec 4;17(23):3880. doi: 10.3390/cancers17233880. PMID: 41375081. Review. ˍ

Harary PM, Hori YS, Annagiri S, Abe K, Tatekoshi Y, Hosoda R, Saga Y, Park DJ, Kuno A, Chang SD.
Enhancing radiation sensitivity in malignant brain tumors with chloroquine: a systematic review.
J Neurooncol. 2025 Dec 5;176(1):106. doi: 10.1007/s11060-025-05362-w. PMID: 41348255. Review˰ ˍ

Nabavizadeh A, Narsinh K, Kaufmann TJ, Liu H, Pouliopoulos AN, Prada F, Agarwal V, Ellingson BM, Sanvito F, Everson RG, Meng Y, Gandhi D, Chang SM, Wen PY, Ahluwalia MS, Sul N, Hadley L, Leblang S, Shah BR, Arvanitis CD, Burns TC, Moosa S, Woodworth GF.
Focused Ultrasound in Brain Tumors: Mechanisms, Imaging Guidance, and Emerging Clinical Applications.
AJNR Am J Neuroradiol. 2025 Dec 5:ajnr.A9126. doi: 10.3174/ajnr.A9126. PMID: 41360502. Review˰ ˍ

Wei Y, Shi Y, Wang H, Shang Y, Yu B, Zhang Y.
Glioblastoma insights: Focus on crosstalk with the suppressive tumor microenvironment and advanced therapeutic strategies.
Medicine (Baltimore). 2025 Dec 5;104(49):e46285. doi: 10.1097/MD.0000000000046285. PMID: 41366964. Review. ˍ

Kaina B, Christmann M.
Senotherapeutics in Malignant Brain Cancer Therapy.
Curr Oncol Rep. 2025 Dec 6. doi: 10.1007/s11912-025-01733-8. PMID: 41350483. Review. ˍ

Bayona C, Ranđelović T, Ochoa I.
Tumor Microenvironment in Glioblastoma: The Central Role of the Hypoxic-Necrotic Core.
Cancer Lett. 2025 Dec 9:218216. doi: 10.1016/j.canlet.2025.218216. PMID: 41380902. Review. ˍ

Hsueh B, Steuart SJ, Odukoya AO, Prager BC, Kim YJ, Hill CM, Choi BD, Dunn GP.
Immunotherapy and targeted therapy for high grade gliomas: current and future directions.
J Neurooncol. 2025 Dec 9;176(1):112. doi: 10.1007/s11060-025-05315-3. PMID: 41366148. Review˰ ˍ

Mizutani Y, Hori YS, Harary PM, Annagiri S, Jain R, Liu J, Izhar M, Reesh DA, Lam FC, Emrich SC, Ustrzynski L, Tayag A, Park DJ, Chang SD.
Radiosurgical management of pathology-proven low-grade glioma: a systematic review across the pre- and post-molecular classification era.
J Neurosurg Sci. 2025 Dec 9. doi: 10.23736/S0390-5616.25.06656-1. PMID: 41364089. Review. ˍ

Preetam S, Rabbee MF, Mishra R, Thapliyal S, Deshwal R, Rustagi S, Dashmana A, Govindarajan RK, Malik S.
Targeting brain tumours with precision: advances in magnetic nanoparticle therapy.
Nanoscale Adv. 2025 Dec 9. doi: 10.1039/d5na01046b. PMID: 41404476. Review. ˍ

Wang J, Zhang Y, Kang Z, Li S, Zhang R, Huang M, Wang C, Fan Y, Liu X, Chen Y, Han T, Wang Y, Li W.
Bidirectional Causal Effect Between Gut Microbiota and Glioma Risk: A Systematic Review-Based Mendelian Randomization and Immune-Mediated Effect Analysis.
Cancer Innov. 2025 Dec 9;4(6):e70039. doi: 10.1002/cai2.70039. PMID: 41384027. Review. ˍ

Sarfraz Z, Ranjan T, Mustafayev FNA, Jaramillo M, Odia Y, Venur VA, Ahluwalia MS.
Emerging therapies for glioblastoma.
J Neurooncol. 2025 Dec 10;176(1):116. doi: 10.1007/s11060-025-05248-x. PMID: 41372729. Review˰ ˍ

Zam A, Rouatbi N, Walters AA, Al-Jamal KT.
Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma.
Adv Drug Deliv Rev. 2025 Dec 10;229:115759. doi: 10.1016/j.addr.2025.115759. PMID: 41386501. Review. ˍ